
TSE:FFH
This summary was created by AI, based on 22 opinions in the last 12 months.
Fairfax Financial (FFH-T) presents a mix of opinions among analysts, characterized by a stable yet turbulent market presence. While it boasts a solid reputation as a well-managed company with strong long-term growth potential, particularly in its insurance sector, many experts imply that the current market conditions are not optimal for buying. Reviews suggest a sideways trend in stock performance without any significant catalysts on the horizon, with some indicating that the best earnings cycle may be behind. Moreover, the stock tends to trade at a discount compared to peers, hinting at potential undervaluation, but several analysts believe that it may not be a screaming buy at this moment. The long-term outlook remains positive, though considerable patience is required to fully appreciate the investment's value.
He admires management very much. It is interesting that they are getting a reasonable toe-hold in India. They seem to have a good knowledge of that area. They were negative on equity markets for some time, but Prem Watsa has finally come around that this market is going to run a little further. Hopes they get a little more aggressive. Expects you will see better results over the next 12 months.
Sell or Hold? This is very difficult to analyse. It’s like a black box and he doesn’t know what the earnings are going to be. There is the insurance side, but he doesn’t know exactly what the investments are all the time. For the first 7-8 years after the crash, because Prem Watsa owned all these Puts, it did really well in the crash, and he was able to grow BV on the insurance side and made gains on the portfolio, but you never knew where they where. Prem finally had a loss on the Puts but was overwhelmed by gains on the other stuff. He owns a lot of their bonds and preferreds. Because of their uncertainty, they always trade at a discount, so the yields are higher.
This is essentially a bet on the acumen of Prem Watsa. Fairfax just bought Allied World for $4.9 billion, which gives them the brokerage market and the Fortune 1000 companies. The stock is off 15% because of his bet on it being deflationary where he lost $5 billion, but he made 5 billion on the other side in terms of his investments. Dividend yield of 2%. (Analysts’ price target is $553.13.)
Owns some of their preferred shares. Doesn’t think he would buy the common shares now. Has a huge insurance operation in many, many countries. He likes what they do. They made a major mistake during the recession, when they hedged on the basis of the market going to go down, but the market has done fantastic.
Technically, the chart is showing a bearish triangle, and we haven’t broken above that. When you break below a support line, you want to break above it before you consider it. This is not the seasonal period for this company. If you are interested in this, wait until it goes above $600 and then have a look.
This had a spectacular growth spurt, and since that time the growth has pretty much levelled out for a long time. Now it just kind of trades in a nice trading range. As time has gone on, the market has become less and less interested, as Prem Watsa has not been able to deliver the returns of the glory days. The stock price and Fair Market Value, as he measures it, are exactly the same. He is concerned that there may be a further set back.
Prem Watsa has an enviable track record of calling the market and making long-term investments. The issue is always trusting his ability to make the right calls. So far, he’s proven he’s worth it. The company has been fairly bearish on the market for a long time, so the results haven’t really kept up with what the index has been doing. Thinks they’ll be able to create value over the long-term.
Has been watching this for a very long time. He likes Prem Watsa and the company, but Prem was doing some goofy things with hedging, etc. and it showed in the stock price. He just bought this and thinks there is a lot more room to go. Prem has got back to the basics of investing, and he thinks this is going right back to the top of its trading range of around $750. (Analysts' price target is $699.16.)